However, diagnostic CT/MRI may be warranted in some patient subgroups with higher PLC risk, such as those with Child-Pugh B cirrhosis, clinically significant portal hypertension, or elevated AFP levels. The gene discussed is AFP; the disease is Cirrhosis.